This is a preview of subscription content, log in via an institution to check access.
Notes
hospital admissions, surgical procedures, outpatient procedures, urology visits and chemotherapy
Reference
Stevenson SM, et al. Cost-effectiveness analysis of neoadjuvant chemotherapy in patients with muscle-invasive bladder cancer. 2013 Genitourinary Cancers Symposium : abstr. 258, 14 Feb 2012.
Rights and permissions
About this article
Cite this article
Cost of neoadjuvant chemotherapy for bladder cancer favourable. PharmacoEcon Outcomes News 673, 6 (2013). https://doi.org/10.1007/s40274-013-0205-0
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0205-0